KRas-induced actin-interacting protein (KRAP), now designated IP3 receptor-interacting domain-containing protein 2 (ITPRID 2), was originally identified as a large actin-binding protein that is over-expressed in a colon cancer cell line expressing activated KRas33. This evidence concerns the gene ITPRID2 and malignant colon neoplasm.